Pricing Log in Create free account

CDT Equity Inc. (CDT) vs Vincerx Pharma, Inc. (VINC)

CDT Equity Inc. and Vincerx Pharma, Inc. are both Biotechnology companies. CDT Equity Inc. is the larger, with a market value of $390.0K against $250.0K — 1.6× the size. Across the 9 metrics below, CDT Equity Inc. leads on 5 and Vincerx Pharma, Inc. on 4.

Valuation

Metric CDT VINC Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.00 0.03 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.17 0.66
EV/Sales n/m n/m 9.02
Earnings yield (10,527,125.00%) (46,330.00%) (32.88%)
Free cash flow yield (43,606.95%) (32,262.57%) (23.13%)

Profitability

Metric CDT VINC Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.68%) (3,136.43%) (51.96%)
Return on assets (55.16%) (287.21%) (46.06%)
Return on invested capital (21.28%) 0.00% 0.00%

Growth

Metric CDT VINC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 98.09% 58.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT VINC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.13 1.79 4.97
Net debt to EBITDA 0.05 0.17 1.01

Dividend

Metric CDT VINC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDT VINC Biotechnology median
Market cap 390.00k 250.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack